Company intelligence / Profile preview

Roslin Technologies

Midlothian, Scotland, United Kingdomroslintech.com ↗

Ownership: Private
Development stage: Other

Overview

Roslin Technologies has developed and commercialized proprietary pluripotent animal stem cells capable of self-renewal and differentiation into muscle and fat tissues. These are supplied globally to cultivated meat producers. The company does not conduct clinical trials as it operates in the food/agriculture sector rather than pharmaceuticals.

Modalities: Induced pluripotent stem cell therapyCell therapy
Industry: Non-Drug Biotech

Partnerships

University of Edinburgh/Roslin Institute/Royal School of Veterinary Studies

Beyond the preview

Go deeper on Roslin Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Roslin Technologies.

Explore the full profile